Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India-Reference-Cited by-同舟云学术

Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part II: INASL Recommendations for Management of HCV in India

Published:2014-06 Issue:2 Volume:4 Page:117-140
ISSN:0973-6883
Container-title:Journal of Clinical and Experimental Hepatology
language:en
Short-container-title:Journal of Clinical and Experimental Hepatology

Author:

Puri Pankaj,Anand Anil C.,Saraswat Vivek A.,Acharya Subrat K.,Sarin Shiv K.,Dhiman Radha K.,Aggarwal Rakesh,Singh Shivaram P.,Amarapurkar Deepak,Arora Anil,Chhabra Mohinish,Chetri Kamal,Choudhuri Gourdas,Dixit Vinod K.,Duseja Ajay,Jain Ajay K.,Kapoor Dharmesh,Kar Premashis,Koshy Abraham,Kumar Ashish,Madan Kaushal,Misra Sri P.,Prasad Mohan V.G.,Nagral Aabha,Puri Amarendra S.,Jeyamani R.,Saigal Sanjiv,Shah Samir,Sharma Praveen K.,Sood Ajit,Thareja Sandeep,Wadhawan Manav

Publisher

Elsevier BV

Subject

Hepatology

Reference143 articles.

1. Interferon alfa-2b alone or in combination with RBV as initial treatment for chronic hepatitis C;McHutchison;N Engl J Med,1998

2. Randomised trial of interferon alpha2b plus RBV for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus;Poynard;Lancet,1998

3. Treatment of chronic hepatitis C in Asia: when east meets west;Yu;J Gastroenterol Hepatol,2009

4. Recommendations for Testing, Managing, and Treating Hepatitis C;AASLD and the Infectious Diseases Society of America (IDSA),2014

5. EASL Recommendations on Treatment of Hepatitis C,2014

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimating the net value of treating hepatitis C virus using sofosbuvir-velpatasvir in India;PLOS ONE;2021-07-22

2. Cost-effectiveness and budgetary impact of HCV treatment with direct-acting antivirals in India including the risk of reinfection;PLOS ONE;2019-06-06

3. Role ofVDR,GC, andCYP2R1Polymorphisms in the Development of Hepatocellular Carcinoma in Hepatitis C Virus-Infected Patients;Genetic Testing and Molecular Biomarkers;2019-05

4. A systematic review of standard treatment guidelines in India;Indian Journal of Medical Research;2019

5. Impact of "Sambhav" Program (Financial Assistance and Counselor Services) on Hepatitis C Pegylated Interferon Alpha Treatment Initiation in India;International Journal of Health Policy and Management;2018-09-11